TAS1440

· Taiho Oncology, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TAS1440, covering 2024-12-09 to 2024-12-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of TAS1440 With ATRA in Subjects With r/r AML [Phase 1]